Ibrutinib Delays ALS Installation and Increases Survival of SOD1G93A Mice by Modulating PI3K/mTOR/Akt Signaling
Chengyou Zheng, Weifen Li, Tahir Ali, Ziting Peng, Jieli Liu, Zhengying Pan, Jinxing Feng, Shupeng Li
Topics & Concepts
MedicineIbrutinibProtein kinase BPI3K/AKT/mTOR pathwayNeuroinflammationSOD1InflammationAtrophyPharmacologyAmyotrophic lateral sclerosisInternal medicineSignal transductionLeukemiaBiologyChronic lymphocytic leukemiaDiseaseBiochemistryAmyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchHistone Deacetylase Inhibitors Research